| Literature DB >> 29417260 |
Katia Herz1, Alexandra Becker1, Chenyue Shi2, Masatsugo Ema3, Satoru Takahashi4, Michael Potente2,5,6, Michael Hesse1, Bernd K Fleischmann1, Daniela Wenzel7.
Abstract
Endothelial cell proliferation is a key process during vascular growth but its kinetics could only be assessed in vitro or ex vivo so far. To enable the monitoring and quantification of cell cycle kinetics in vivo, we have generated transgenic mice expressing an eGFP-anillin construct under control of the endothelial-specific Flt-1 promoter. This construct labels the nuclei of endothelial cells in late G1, S and G2 phase and changes its localization during the different stages of M phase, thereby enabling the monitoring of EC proliferation and cytokinesis. In Flt-1/eGFP-anillin mice, we found eGFP+ signals specifically in Ki67+/PECAM+ endothelial cells during vascular development. Quantification using this cell cycle reporter in embryos revealed a decline in endothelial cell proliferation between E9.5 to E12.5. By time-lapse microscopy, we determined the length of different cell cycle phases in embryonic endothelial cells in vivo and found a M phase duration of about 80 min with 2/3 covering karyokinesis and 1/3 cytokinesis. Thus, we have generated a versatile transgenic system for the accurate assessment of endothelial cell cycle dynamics in vitro and in vivo.Entities:
Keywords: Angiogenesis; Anillin; Cell cycle; Endothelial cell; Proliferation
Mesh:
Substances:
Year: 2018 PMID: 29417260 DOI: 10.1007/s10456-018-9601-1
Source DB: PubMed Journal: Angiogenesis ISSN: 0969-6970 Impact factor: 9.596